Brief: Saniona, Acadia Announce Initial Positive Results From ACP-711 Phase 1 Study

Acadia Pharmaceuticals

03/03/2025 14:33

March 3 (Reuters) - ACADIA Pharmaceuticals Inc ACAD.O:

ACADIA PHARMACEUTICALS AND SANIONA ANNOUNCE INITIAL POSITIVE RESULTS FROM ACP-711 (FORMERLY SAN711) PHASE 1 STUDY

IN STUDY, ACP-711 WAS SAFE AND GENERALLY WELL TOLERATED ACROSS ALL DOSING COHORTS

THERE WERE NO SERIOUS ADVERSE EVENTS

NO SAFETY LABORATORY CONCERNS, CARDIOVASCULAR CONCERNS, OR ABNORMAL NEUROLOGICAL FINDINGS WERE OBSERVED

Source text: ID:nMFN6HH2Qx

Further company coverage: ACAD.O

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))